Paragon 28 (NYSE:FNA) Trading Up 4.1%

Shares of Paragon 28, Inc. (NYSE:FNA) shot up 4.1% during mid-day trading on Wednesday . The company traded as high as $6.65 and last traded at $6.61. 112,514 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 606,143 shares. The stock had previously closed at $6.35.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on FNA. Stephens reiterated an “overweight” rating and issued a $18.00 target price on shares of Paragon 28 in a research note on Friday, April 5th. Needham & Company LLC cut their target price on Paragon 28 from $17.00 to $14.00 and set a “buy” rating on the stock in a research note on Thursday, May 9th. Piper Sandler reiterated an “overweight” rating and issued a $15.00 target price (down from $18.00) on shares of Paragon 28 in a research note on Thursday, May 9th. Finally, JMP Securities cut their target price on Paragon 28 from $23.00 to $20.00 and set a “market outperform” rating on the stock in a research note on Thursday, May 9th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Paragon 28 currently has an average rating of “Buy” and an average target price of $16.75.

Paragon 28 Price Performance

The company has a quick ratio of 1.78, a current ratio of 3.57 and a debt-to-equity ratio of 0.67. The company has a fifty day moving average of $7.97 and a two-hundred day moving average of $10.45.

Paragon 28 (NYSE:FNA) last announced its quarterly earnings results on Wednesday, May 8th. The company reported ($0.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.07). Paragon 28 had a negative net margin of 24.45% and a negative return on equity of 27.72%. The company had revenue of $61.08 million during the quarter. Equities analysts expect that Paragon 28, Inc. will post -0.58 earnings per share for the current year.

Institutional Investors Weigh In On Paragon 28

Large investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD raised its holdings in shares of Paragon 28 by 16.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock worth $156,000 after buying an additional 1,766 shares in the last quarter. Capstone Investment Advisors LLC boosted its position in shares of Paragon 28 by 9.0% during the 1st quarter. Capstone Investment Advisors LLC now owns 21,800 shares of the company’s stock valued at $269,000 after purchasing an additional 1,800 shares in the last quarter. PNC Financial Services Group Inc. bought a new stake in shares of Paragon 28 during the 4th quarter valued at about $25,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Paragon 28 by 26.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,886 shares of the company’s stock worth $173,000 after buying an additional 2,902 shares during the period. Finally, HighMark Wealth Management LLC acquired a new position in Paragon 28 during the 4th quarter worth approximately $99,000. 63.57% of the stock is currently owned by institutional investors.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.